Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-09

FDA Approved: ANTI-DIARRHEAL — Supplemental Application (Better Living Brands, LLC)

View source ↗

Summary

FDA approved a supplemental application for the anti-diarrheal product ANTI-DIARRHEAL, associated with loperamide hydrochloride (Loperamide HCl) under an ANDA f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOPERAMIDE HCL (LOPERAMIDE HYDROCHLORIDE)

Snippet

SUPPL AP for ANTI-DIARRHEAL (LOPERAMIDE HCL)